We analyzed the effect of dasatinib treatment ex vivo on CRKL phosphorylation in three CP CML BM samples of unsorted MNCs using western blotting. The gene discussed is CRKL; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.